Insight Molecular Diagnostics Inc. Net Asset Quality Index
Insight Molecular Diagnostics Inc. net asset quality index. Insight Molecular Diagnostics Inc. (IMDX) has a Net Asset Quality Index of -72.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $29.44 Million minus total liabilities of $50.74 Million yields net assets of $-21.30 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check IMDX cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Insight Molecular Diagnostics Inc. (2013–2025)
Net asset quality index of Insight Molecular Diagnostics Inc. from 2013 to 2025. This chart shows how Insight Molecular Diagnostics Inc.'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at -72.3%, representing net assets of $-21.30 Million against total assets of $29.44 Million USD. See IMDX net assets for net asset value and shareholders' equity analysis.
Insight Molecular Diagnostics Inc. Net Asset Quality Index by Year (2013–2025)
Insight Molecular Diagnostics Inc. net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Insight Molecular Diagnostics Inc. from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IMDX stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -122.2% | $-31.46 Million | $25.76 Million | $57.22 Million | ▼ -87.2 pp |
| 2024 | -35.0% | $-12.27 Million | $35.08 Million | $47.35 Million | ▼ -62.3 pp |
| 2023 | 27.3% | $20.47 Million | $74.89 Million | $54.42 Million | ▼ -12.2 pp |
| 2022 | 39.6% | $39.59 Million | $100.09 Million | $60.50 Million | ▼ -1.3 pp |
| 2021 | 40.9% | $65.22 Million | $159.56 Million | $94.35 Million | ▼ -19.5 pp |
| 2020 | 60.4% | $33.48 Million | $55.42 Million | $21.94 Million | ▼ -16.9 pp |
| 2019 | 77.4% | $30.84 Million | $39.86 Million | $9.02 Million | ▲ +41.4 pp |
| 2018 | 36.0% | $3.42 Million | $9.52 Million | $6.09 Million | ▼ -7.1 pp |
| 2017 | 43.1% | $4.40 Million | $10.22 Million | $5.81 Million | ▼ -25.2 pp |
| 2016 | 68.3% | $9.86 Million | $14.45 Million | $4.58 Million | ▼ -13.6 pp |
| 2015 | 81.8% | $10.42 Million | $12.73 Million | $2.31 Million | ▲ +98.7 pp |
| 2014 | -16.9% | $-1.07 Million | $6.36 Million | $7.43 Million | ▼ -60.5 pp |
| 2013 | 43.6% | $3.62 Million | $8.29 Million | $4.67 Million | — |